Table 2 Information on endpoints of the main trial considered as outcomes for the health economic evaluation of the ALVEEG study

Primary outcome

 Proportion of clinical questions resolved in the IG versus the CG

X

X

At discussion of medical findings (patient, neurologist)

Secondary outcomes

 # hospital stays

X

X

Starting between enrollment and 3 months after discussion of medical findings

 Cumulative length of hospital stays for hospitalized patients

X

X

Starting between enrollment and 3 months after discussion of medical findings

 Quality of Life

X

X

At baseline and 3 months after discussion of medical findings